title: Prescription medication use by Canadians aged 6 to 79.
abstract: Based on data from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey, this article provides national information about prescription medication use among community-dwelling Canadians. An estimated 41% of 6- to 79-year-olds who lived in private households reported taking at least one prescription medication in the past two days (current use). Generally, prescription drug use was higher among females and among people in poorer health, and increased with age. Approximately 11% of 45- to 64-year-olds and 30% of seniors aged 65 to 79 took at least five prescription medications concurrently. For adults aged 25 to 79, the leading prescription medication classes were lipid-lowering agents, ACE-inhibitors, peptic-ulcer and acid-reducers, beta-blockers (men), other analgesics and anti-pyretics (men), anti-depressants (women) and thyroid medication (women). Among children and young adults aged 6 to 24, the leading prescription medications were for attention deficit and hyperactivity disorder (males), depression, and hormonal contraception (females).
authors.affiliation: Health Analysis Division, Statistics Canada, Ottawa, Ontario K1A0T6.
authors.forename: Michelle
authors.initials: M
authors.lastname: Rotermann
authors.affiliation: Health Analysis Division, Statistics Canada, Ottawa, Ontario K1A0T6.
authors.forename: Claudia
authors.initials: C
authors.lastname: Sanmartin
authors.affiliation: Health Analysis Division, Statistics Canada, Ottawa, Ontario K1A 0T6.
authors.forename: Deirdre
authors.initials: D
authors.lastname: Hennessy
authors.affiliation: Canadian Institute for Health Information, Ottawa, Ontario K2A 4H6.
authors.forename: Michele
authors.initials: M
authors.lastname: Arthur
mesh_terms: D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D058633:Antipyretics / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D002170:Canada / Q000453:epidemiology; D002648:Child; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D055553:Prescription Drugs / Q000627:therapeutic use*; D012737:Sex Factors; D055815:Young Adult
chemical_list: D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000806:Angiotensin-Converting Enzyme Inhibitors; D000897:Anti-Ulcer Agents; D000928:Antidepressive Agents; D058633:Antipyretics; D013956:Antithyroid Agents; D000960:Hypolipidemic Agents; D055553:Prescription Drugs
keywords: Chronic conditions; drug therapy; polypharmacy